Eli Lilly is at the forefront of the GLP-1 weight loss drug market. The company’s leading position is already being tested by Novo Nordisk’s GLP-1 weight loss pill.
Source: https://www.fool.com/investing/2026/01/23/forget-eli-lilly-b…
The Zacks Transportation-Truck industry is suffering mainly due to lackluster freight demand. We believe stocks like JBHT, SAIA and ARCB are better positioned to escape industry challenges.
Donald Trump kicked off a marijuana stock rally before Friday’s stock market open.
While it may not be anything like the 7% to 8% inflation rate of 2022 and 2023, the consensus view is that inflation will remain above the Federal Reserve’s preferred 2% target for some time to come. That makes dividend stocks more attractive, particularly those with yields that outpace the rate of inflation.
